Effects of vancomycin, teicoplanin, linezolid, quinupristin-dalfopristin, and telithromycin on murine gut colonization by Candida albicans

Medical Mycology

Volumn 44, Issue 2, 2006, Pages 193-196

  Samonis, George ^a,b   Maraki, S ^a   Barbounakis, E ^a   Leventakos, K ^a   Lamaris, G ^a   Rovithi, M ^a   Hatjiioannou, I ^a   Potolidis, E ^a   Tselentis, Y ^a   Mantadakis, E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Candida albicans; Gastrointestinal tract; Linezolid; Mice; Quinupristin dalfopristin; Teicoplanin; Telithromycin; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; SODIUM CHLORIDE; TEICOPLANIN; TELITHROMYCIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL OBSERVATION; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG EFFICACY; DRUG FECES LEVEL; FECES CULTURE; FEEDING; FUNGAL COLONIZATION; GRAM POSITIVE BACTERIUM; INTESTINE FLORA; INTESTINE INFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; FECES; GASTROINTESTINAL DISEASES; MICE; MICE, INBRED ICR;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MURINAE; POSIBACTERIA;

EID: 31344449265     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500265980     Document Type: Article

References (19)

1. Warnock, DW. (1998) Fungal infections in neutropenia: Current problems and chemotherapeutic control J Antimicrob Chemother, 41(Suppl. D), pp. 95-105.
2. Benedict, S and Colagreco, J. (1994) Fungal infections associated with malignancies, treatments, and AIDS Cancer Nurs, 17, pp. 411-417.
3. Nucci, M and Anaissie, E. (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis, 33, pp. 1959-1967.
4. Reagan, DR and Pfaller, MA and Hollis, RJ and Wenzel, RP. (1990) Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe J Clin Microbiol, 28, pp. 2733-2738.
5. Kennedy, MJ and Volz, PA. (1985) Ecology of Candida albicans gut colonization: Inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism Infect Immun, 49, pp. 654-663.
6. Samonis, G and Gikas, A and Toloudis, P and (1994) Prospective study of the impact of broad spectrum antibiotics on the yeast flora of the human gut Eur J Clin Microbiol Infect Dis, 13, pp. 665-667.
7. Maraki, S and Mouzas, IA and Kontoyiannis, DP and (2001) Prospective evaluation of the impact of amoxicillin, clarithromycin and their combination on human gastrointestinal colonization by Candida species Chemotherapy, 47, pp. 215-218.
8. Krause, W and Matheis, H and Wulf, K. (1969) Fungemia and funguria after oral administration of Candida albicans Lancet, 1, pp. 598-599.
9. Samonis, G and Anaissie, EJ and Rosenbaum, B and Bodey, GP. (1990) A model of sustained gastrointestinal colonization by Candida albicans in healthy adult mice Infect Immun, 58, pp. 1514-1517.
10. Freireich, E and Gehan, EA and Rall, DP and Schmidt, LH and Skipper, HE. (1966) Quantitative comparison of toxicity to anticancer agents in mouse, rat, hamster, dog, monkey, and man Cancer Chemother Rep, 50, pp. 219-244.
11. Sullivan, A and Edlund, C and Nord, CE. (2001) Effect of antimicrobial agents on the ecological balance of human microflora Lancet Infect Dis, 1, pp. 101-114.
12. Smonis, G and Anastassiadou, H and Dassiou, M and Tselentis, Y and Bodey, GP. (1994) Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans Antimicrob Agents Chemother, 38, pp. 602-603.
13. Fekerty, R. (2000) Vancomycin, teicoplanin and the streptogramins: quinupristin and dalfopristin. In Principles and Practice of Infectious Diseases 5th edn. (pp. 382-392). Philadelphia: Churchill Livingstone.
14. Diekema, DJ and Jones, RN. (2001) Oxazolidinone antibiotics Lancet, 358, pp. 1975-1982.
15. Boswell, FJ and Andrews, JM and Ashby, JP and (1998) The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent J Antimicrob Chemother, 42, pp. 703-709.
16. Bergeron, M and Montay, G. (1998) The pharmacokinetics of quinupristin/ dalfopristin in laboratory animals and in humans J Antimicrob Chemother, 39(Suppl. A), pp. 129-138.
17. Lode, H and von der Hoh, N and Ziege, S and Borner, K and Nord, CE. (2001) Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora Scand J Infect Dis, 33, pp. 899-903.
18. Edlund, C and Alvan, G and Barkholt, L and Vacheron, F and Nord, CE. (2000) Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora J Antimicrob Chemother, 46, pp. 741-749.
19. Scanvic-Hameg, A and Chachaty, E and Rey, J and (2002) Impact of quinupristin/dalfopristin (RP59500) on the faecal microflora in healthy volunteers J Antimicrob Chemother, 49, pp. 135-139.